(redirected from Hypertrophic scars)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • noun
  • verb

Synonyms for scar

Synonyms for scar

a mark left (usually on the skin) by the healing of injured tissue

an indication of damage

References in periodicals archive ?
Asiaticoside, an active component of Centella asiatica, is known for beneficial effects on keloid and hypertrophic scar.
Standard guidelines of care: Keloids and hypertrophic scars.
Endo has also discussed the potential expansion of its CCH development pipeline into currently un-licensed assets including uterine fibroids, human lipoma, capsular contracture of the breast, Dercum's disease, knee arthrofibrosis, urethral strictures, hypertrophic scars and keloids.
EXC 001 or placebo was administered intradermally in 21 subjects who were undergoing elective revision of hypertrophic scars of the breast.
These medical-grade siliconebased products are designed to improve the appearance of keloids and hypertrophic scars resulting from surgery or trauma to the skin.
True (A) or false (B)--fill in only block A or B: Corticosteroid injections are used as first-line therapy for hypertrophic scars.
PARIS -- In high-risk patients, the prophylactic use of silicone gel sheeting immediately after surgery reduces by nearly half the chances of hypertrophic scars and keloids developing afterward, Dr.
Hypertrophic scars rather frighteningly go on thickening for up to six months and may be itchy or painful.
RXi Pharmaceuticals Corporation (OTC: RXII), today announced that dosing with their anti-scarring drug, RXI-109, for the management of surgical and hypertrophic scars and keloids has been initiated.
We are very pleased with the outcome of the 3-month evaluation of our ongoing Phase 2a study with RXI-109 for the treatment of hypertrophic scars following scar revision surgery," said Dr.
Scar formation after cutaneous trauma, surgical or otherwise, encompasses a broad spectrum, ranging from normal scars to hypertrophic scars to keloids.
This drug candidate is a highly selective CTGF targeting sd-rxRNA[R] compound that is administered through intradermal injections toprevent or reduce dermal scarring following surgery or trauma, as well as for the management of hypertrophic scars and keloids.
Currently, there are three ongoing Phase 2a trials evaluating the effect of RXI-109 on scar formation in the skin after surgical revision of hypertrophic scars or keloids.
Outcomes are different, as well; keloids tend to grow and recur, while hypertrophic scars often regress with time.